Literature DB >> 23896491

Clinical features of 149 patients with facio-auriculo-vertebral spectrum.

Liliana A Muñoz-Pedroza1, María L Arenas-Sordo.   

Abstract

Facio-Auriculo-Vertebral (FAV) spectrum, also known as Goldenhar syndrome or first and second branchial arch syndrome, is a complex of mainly craniofacial and vertebral anomalies. Microtia is a principal malformation in this complex; it can be unilateral or bilateral. We performed an observational, retrospective, transverse descriptive clinical study, reviewing 149 records of patients with a diagnosis of microtia treated in the Genetics Department. There was no significant difference in the sex of the individuals involved. The mean age was 6.97 years, with a range of 1 to 52 years. We founded positive inbreeding in 14 patients and consanguinity in 1 case. There was a family history of microtia in 37 cases. The most frequent malformations, besides microtia, were facial, costo-vertebral, limb, cardiac, genital, eye and other defects. Patients had a high percentage of family history, which could suggest an autosomal dominant inheritance with reduced penetrance.
Copyright © 2013 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  Espectro facio-aurículo-vertebral; Facio-auriculo-vertebral sequence; Goldenhar; Goldenhar syndrome; Hemifacial microsomia; Microsomía hemifacial; Microtia

Mesh:

Year:  2013        PMID: 23896491     DOI: 10.1016/j.otorri.2013.03.007

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  3 in total

1.  Goldenhar syndrome with right circumflex aortic arch, severe coarctation and vascular ring in a twin pregnancy.

Authors:  Elaheh Malakan Rad
Journal:  Ann Pediatr Cardiol       Date:  2014-09

Review 2.  Goldenhar syndrome: Cardiac anesthesiologist's perspective.

Authors:  Minati Choudhury; Poonam Malhotra Kapoor
Journal:  Ann Card Anaesth       Date:  2017-01

3.  Bezold's abscess secondary to os tympanicum cholesteatoma in Goldenhar syndrome.

Authors:  Matteo Minerva; Silvia Valeggia; Stefano Fusetti; Elisabetta Zanoletti; Renzo Manara; Davide Brotto
Journal:  BJR Case Rep       Date:  2021-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.